Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supersaturated calcium phosphate is an electrolyte solution used primarily for the prevention and treatment of oral mucositis, particularly in patients undergoing hematopoietic stem cell transplantation or intensive radiation and chemotherapy. It is typically supplied as two separate aqueous solutions—one containing calcium salts and the other containing phosphate salts—which are mixed immediately before administration to create a supersaturated environment. This solution mimics natural saliva and provides a high concentration of ions that facilitate the remineralization of dental enamel and provide a protective, lubricating coating over the oral mucosa. This mechanical action helps to reduce the severity of mucosal inflammation, alleviate pain, and support the healing of oral lesions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on supersaturated calcium phosphate.